ATP

Overview

An adenine nucleotide containing three phosphate groups esterified to the sugar moiety. In addition to its crucial roles in metabolism adenosine triphosphate is a neurotransmitter.

Background

An adenine nucleotide containing three phosphate groups esterified to the sugar moiety. In addition to its crucial roles in metabolism adenosine triphosphate is a neurotransmitter.

Indication

For nutritional supplementation, also for treating dietary shortage or imbalance

Associated Conditions

Supraventricular Arrhythmias

Clinical Trials

Title	Posted	Study ID	Phase	Status	Sponsor
Improvement of Depression With Use of ATP	2024/02/20	NCT06266715	Not Applicable	Recruiting	Nanfang Hospital, Southern Medical University
Role of Acetylcholine in Blood Flow Regulation in Healthy Adults: Effects of Age and Exercise Training	2019/06/04	NCT03972683	Early Phase 1	Withdrawn	Colorado State University
Pyridoxine, P2 Receptor Antagonism, and ATP-mediated Vasodilation in Young Adults	2018/11/13	NCT03738943	Early Phase 1	Completed	Colorado State University
Functional Magnetic Resonance Imaging of ATP Cough in Chronic Cough Patients	2018/10/29	NCT03722849	Not Applicable	Completed	Stuart Mazzone
Rapid Antidepressant Effects of ATP and Phosphocreatine	2017/05/03	NCT03138681	Phase 2	UNKNOWN	Zhujiang Hospital
A Time-to-effect Based Dosing Strategy in Cryoballoon Ablation of Patients With Paroxysmal Atrial Fibrillation	2016/06/03	NCT02789358	Not Applicable	Completed	Fundación para la Investigación del Hospital Clínico de Valencia
ATP in Alzheimer Disease	2014/10/31	NCT02279511	Phase 2	Completed	Sara Varea
the Effectiveness of Probiotics on Atopic Dermatitis With Cow Milk Allergy	2010/01/11	NCT01045486	Not Applicable	Withdrawn	Soonchunhyang University Hospital
Application of ATP Infusions in Palliative Home Care	2007/11/29	NCT00565188	Phase 3	Completed	Maastricht University Medical Center
Adenosine Triphosphate in Treating Patients With Advanced Solid Tumors	2003/07/30	NCT00014248	Phase 1	Completed	Dartmouth-Hitchcock Medical Center

FDA Drug Approvals

Approved Product	Manufacturer	NDC Code	Route	Strength	Effective Date
Healthy Weight Formula	Healing Power Within Inc.	51264-0001	ORAL	30 [hp_X] in 1 mL	5/23/2025

EMA Drug Approvals

Approved Product	Authorization Holder	Status	Issued Date
No EMA approvals found for this drug.

HSA Drug Approvals

Approved Product	Manufacturer	Approval Number	Dosage Form	Strength	Approval Date
No HSA approvals found for this drug.

NMPA Drug Approvals

Approved Product	Company	Approval Number	Drug Type	Dosage Form	Approval Date
No NMPA approvals found for this drug.

PPB Drug Approvals

Approved Product	Registration No.	Company	Licence No.	Strength	Registration Date
No PPB approvals found for this drug.

TGA Drug Approvals

Approved Product	ARTG ID	Sponsor	Registration Type	Status	Registration Date
THE GROWLING DOG ENERGY MIX oral powder jar/can	51968	Musashi Pty Ltd	Medicine	A	3/23/1995

Related News

CEPI Invests $2.87 Million in ACM Biolabs' Thermostable mRNA Vaccine Delivery Platform

2 months ago

• Singapore-based ACM Biolabs receives $2.87 million from CEPI to develop their thermostable mRNA delivery technology that enables vaccine storage at 2-8°C instead of ultra-low temperatures. • The ACM Tunable Platform (ATP) aims to enhance both T-cell activation and antibody response, potentially offering more durable immune protection than conventional mRNA vaccine delivery systems. • Researchers will use Rabies as a model pathogen for preclinical proof of concept studies, with the goal of improving global access to mRNA vaccines through simplified distribution requirements.

UConn Stroke Drug Advances Towards Clinical Trials with NIH Grant

9 months ago

UConn's experimental small-molecule drug has shown promise in reducing damage and restoring function after stroke in animal models.

AI-Powered Research

Premium Access